However, while semaglutide can be an effective tool, it is not a stand-alone solution
Efficacy and safety of novel twincretin tirzepatide, a dual GIP/GLP-1 receptor agonist, as an anti-obesity medicine in individuals without diabetes: a systematic review and meta-analysis
The most common early side effects of semaglutide, tirzepatide, or retatrutide include: Nausea or bloating Constipation Fatigue or low energy Mild dehydration Each of these symptoms can make physical intimacy less appealing
Whether youre interested in current GLP-1 options or want to be among the first to explore retatrutide when it becomes available, advanced wellness options can help you take the next step
Major medical groups encourage women to raise sexual health changes with a clinician, since these shifts are common and treatable, a point reinforced by ACOG patient guidance on sexual health
All Sempica research compounds are supplied for laboratory use only, independently tested, and accompanied by a Certificate of Analysis